Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Diving Hyperb Med ; 48(4): 235-240, 2018 Dec 24.
Artículo en Inglés | MEDLINE | ID: mdl-30517956

RESUMEN

BACKGROUND: Recent studies indicated that ketone ester R,S-1,3-butanediol acetoacetate diester (BD-AcAc2) may be effective in preventing central nervous system oxygen toxicity (CNS-OT) and concomitant acute lung injury, a serious medical problem to be faced when breathing hyperbaric oxygen (HBO). This study aimed to further investigate the protective effects of BD-AcAc2 against CNS-OT and concomitant acute lung injury (ALI) in mice. METHODS: Mice were treated with BD-AcAc2 in peanut oil vehicle (2.5, 5.0 or 10.0 g·kg⁻² body weight) by gavage 20 minutes before 600 kPa HBO exposure. Control mice received the vehicle only. Seizure latency was recorded. Malondialdehyde content in brain and lung tissues, total protein level in bronchoalveolar lavage fluid (BLF) and lung water content were measured 60 minutes after the hyperbaric exposure. Histopathology of lung tissue was undertaken. RESULTS: Compared with the vehicle alone, BD-AcAc2 prolonged seizure latency in a dose-dependent manner (P < 0.01). The HBO-induced increase in brain malondialdehyde, BLF protein and lung water were significantly reduced by BD-AcAc2 (P < 0.01). CONCLUSION: Oral administration of the ketone ester BD-AcAc2 significantly protected against CNS-OT and concomitant ALI. Alleviation of oxidative stress may be one underlying mechanism providing this effect.


Asunto(s)
Acetoacetatos/uso terapéutico , Lesión Pulmonar Aguda , Encéfalo/efectos de los fármacos , Butileno Glicoles/uso terapéutico , Oxigenoterapia Hiperbárica , Acetoacetatos/farmacología , Lesión Pulmonar Aguda/tratamiento farmacológico , Animales , Oxigenoterapia Hiperbárica/efectos adversos , Ratones , Oxígeno , Ratas Sprague-Dawley , Convulsiones/tratamiento farmacológico
2.
J Med Food ; 16(11): 965-7, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24138078

RESUMEN

Ketone bodies are produced in the liver and are utilized in other tissues in the body as an energy source when hypoglycemia occurs in the body. There are three ketone bodies: acetoacetate, beta hydroxy butyrate, and acetone. Ketone bodies are usually present in the blood, and their level increases during fasting and starvation. They are also found in the blood of neonates and pregnant women. In diabetic ketoacidosis, high levels of ketone bodies are produced in response to low insulin levels and high levels of counter-regulatory hormones.


Asunto(s)
Ácido 3-Hidroxibutírico/sangre , Acetoacetatos/sangre , Acetona/sangre , Glucemia/metabolismo , Cetoacidosis Diabética/sangre , Hipoglucemia/sangre , Inanición/sangre , Ácido 3-Hidroxibutírico/uso terapéutico , Acetoacetatos/uso terapéutico , Acetona/uso terapéutico , Enfermedad de Alzheimer/tratamiento farmacológico , Femenino , Salud , Humanos , Recién Nacido/sangre , Embarazo/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA